Persistent transmission of shigellosis in England is associated with a recently emerged multi-drug resistant strain of Shigella sonnei
Megan BardsleyiD, Claire JenkinsiD, Holly D. MitchelliD, Amy F. W. MikhailiD, Kate S. BakeriD, Kirsty Foster, Gwenda HughesiD, Timothy J. DallmaniD
Abstract
BackgroundWhole genome sequencing has enhanced surveillance and facilitated detailed monitoring of transmission of Shigella species in England.\n\nMethodsWe undertook an epidemiological and phylogenetic analysis of isolates from all cases of shigellosis referred to Public Health England between 2015 to 2018 to explore recent strain characteristics and transmission dynamics of Shigella species.\n\nResultsOf the 4950 confirmed cases of shigellosis identified during this period, the highest proportion of isolates were S. sonnei (54.4%), followed by S. flexneri (39.2%), S. boydii (4.1%) and S. dysenteriae (2.2%). Most cases were adults (82.9%) and male (59.5%), and 34.9% cases reported recent travel outside the UK. Throughout the study period diagnoses of S. flexneri and S. sonnei were most common in men with no history of recent travel abroad. Species prevalence was not static with cases of S. flexneri in men decreasing from 2015-2016, and the number of cases of S. sonnei increasing from 2017. Phylogenetic analysis showed this recent increase in S. sonnei was attributed to a novel clade exhibiting resistance to ciprofloxacin and azithromycin, which had emerged from a Central Asia sub-lineage.\n\nConclusionsDespite changes in species prevalence, Shigella diagnoses in England are persistently the most common in adult males without reported travel history, consistent with sexual transmission amongst men who have sex with men. The trend in increasing ciprofloxacin resistance, in addition to plasmid-mediated azithromycin resistance, in S. sonnei is of significant public health concern with respect to transmission of multi-drug resistant gastrointestinal pathogens and the risk of treatment failures.\n\nSummaryShigella diagnoses in England are most prevalent amongst men who have sex with men. S. sonnei exhibiting resistance to both azithromycin and ciprofloxacin has replaced azithromycin-resistant S. flexneri as the most commonly isolated species in this setting.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 69
- FWCI
- 6.64
- Field percentile
- top 3%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phylogenetic and evolutionary analysis reveals the recent dominance of ciprofloxacin resistant S. sonnei and local persistence of S. flexneri clones in India
Dhiviya Prabaa Muthuirulandi Sethuvel, Ankur Mutreja, … Balaji Veeraraghavan·mSpherePeer-reviewed·Oct 6, 2020
- Rapid emergence of extensively drug-resistant Shigella sonnei in France
S. Lefevre, E. Njamkepo, … F.-X. Weill·bioRxiv·Sep 7, 2022
- Comparative genome analysis of 12 Shigella sonnei strains: virulence, resistance, and their interactions
- Incremental AMR acquisition driving successive genotype replacements and the rise of extensively drug resistant (XDR) Shigella sonnei in Australia over 20 years.
Jake A. Lacey, Sally Dougall, … Norelle L. Sherry·bioRxiv·Jun 25, 2026
- Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonnei
J. Hawkey, K. Paranagama, … K. E. Holt·bioRxiv·Oct 29, 2020
- South Asia as a reservoir for the global spread of ciprofloxacin resistant Shigella sonnei
Hao Chung The, Maia A Rabaa, … Stephen Baker·PLOS MedicinePeer-reviewed·Aug 2, 2016